Christopher S Henney's Net Worth

$6.29 Million

Estimate Recalculated Jun 25, 2024 07:02PM EST

Who is Christopher S Henney?

Christopher S Henney has an estimated net worth of $6.29 Million. This is based on reported shares across multiple companies, which include Cascadian Therapeutics, Inc., SGX PHARMACEUTICALS, INC., PROTHENA CORP PUBLIC LTD CO, AVI BIOPHARMA INC, MYMETICS CORP, Cyclacel Pharmaceuticals, Inc., DENDREON CORP, Anthera Pharmaceuticals Inc, and TECHNE CORP /MN/.

SEC CIK

Christopher S Henney's CIK is 0001242880

Past Insider Trading and Trends

2021 was Christopher S Henney's most active year for acquiring shares with 17 total transactions. Christopher S Henney's most active month to acquire stocks was the month of May. 2021 was Christopher S Henney's most active year for disposing of shares, totalling 34 transactions. Christopher S Henney's most active month to dispose stocks was the month of June. 2005 saw Christopher S Henney paying a total of $315,000.00 for 210,000 shares, this is the most they've acquired in one year. In 2021 Christopher S Henney cashed out on 124,000 shares for a total of $3,841,095.05, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Cascadian Therapeutics, Inc. No price found

Interim CEO and President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-60.19K
—
—
0
Mar 9
Form 4
+3.05%
1.78K
$3.94
-$2,340.36
60.19K
Sep 24
Form 4
+13.16%
6.79K
$3.78
-$8,561.70
58.4K
Jun 24
Form 4
+3.22%
1.61K
$3.34
-$1,793.58
51.61K
Jun 9 - Jun 12
Form 4
+102.63%
25.32K
$4.11
$103,972.75
50K
Jan 30
Form 4
—
0
—
—
0
Jun 24
Form 4
—
0
—
—
0
Mar 16
Form 4
—
0
—
—
0
Sep 24
Form 4
+9.72%
12.03K
$3.88
-$15,562.68
135.81K
Jun 12 - Jun 13
Form 4
-1.62%
-2.04K
$3.06
-$6,254.64
123.78K
Jun 6 - Jun 7
Form 4
+13.04%
14.51K
$3.65
-$17,658.70
125.82K
Mar 11
Form 4
—
0
—
—
0
Jun 13
Form 4
-1.01%
-1.14K
$1.86
-$2,111.10
111.31K
Jun 9
Form 4
+7.84%
8.17K
$3.67
$29,998.58
112.44K
Jun 7
Form 4
-1.90%
-2.02K
$3.51
-$7,093.71
104.27K
Jun 3
Form 4
+0.70%
742
$4.15
-$1,025.05
106.29K
May 3
Form 4
+1.73%
1.79K
$7.58
-$4,525.26
105.55K
Dec 31
Form 4
-1.47%
-1.55K
$6.86
-$10,605.56
103.75K
Dec 4
Form 4
+21.66%
18.75K
$6.92
-$43,250.00
105.3K
Dec 1
Form 4
-12.62%
-12.50K
$6.36
-$79,500.00
86.55K
Nov 18
Form 4
+101.93%
50K
—
—
99.05K
Oct 10
Form 4
+15.59%
6.61K
—
—
49.05K
Jun 9 - Jun 12
Form 4
+8.06%
3.17K
—
—
42.44K
Dec 14
Form 4
+25.93%
8.09K
—
—
39.27K
Jun 3
Form 4
+24.74%
6.18K
—
—
31.18K
Dec 4
Form 4
—
0
—
—
0
Jun 12
Form 4/A
—
0
—
—
0
Mar 11
Form 4/A
—
0
—
—
0
Mar 11
Form 4
—
0
—
—
0
Mar 11
Form 4
∞
25K
—
—
25K
Dec 10
Form 3
—
0
—
—
0
No matching records found

SGX PHARMACEUTICALS, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-97.17K
$3.00
-$291,495.00
0
Aug 20
Form 4
—
0
—
—
0
Jun 5
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
May 17
Form 4
—
0
—
—
0
May 17
Form 4
+25.23%
19.58K
—
—
97.17K
Feb 6
Form 3
—
0
—
—
0
No matching records found

PROTHENA CORP PUBLIC LTD CO (PRTA) Snapshot price: $26.2

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$33.40
-$490,166.46
0
Scheduled
Jul 14
Form 4/A
—
0
$32.65
-$1,092,181.51
0
Scheduled
Jul 12
Form 4
—
0
$32.65
-$1,092,181.51
0
Jul 12
Form 4
—
0
$32.08
-$375,659.22
0
Jun 25
Form 4
—
0
—
—
0
May 19
Form 4
—
0
—
—
0
Feb 12
Form 4
—
0
—
—
0
May 20
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
May 16
Form 4
—
0
$38.33
-$57,015.00
0
Scheduled
Sep 28
Form 4
—
0
$36.39
-$297,420.50
0
Scheduled
Jul 17
Form 4
—
0
—
—
0
May 18
Form 4
—
0
$31.90
-$302,523.55
0
Scheduled
Feb 27
Form 4
—
0
$31.86
-$202,207.35
0
Scheduled
Feb 17
Form 4/A
—
0
$34.79
-$562,798.43
0
Aug 7
Form 4
—
0
—
—
0
May 20
Form 4
—
0
$40.83
-$341,750.00
0
Scheduled
Nov 27
Form 4
—
0
$30.83
-$241,750.00
0
Scheduled
Oct 29
Form 4
—
0
$34.67
-$565,198.43
0
Aug 7
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
Mar 18
Form 3
—
0
—
—
0
No matching records found

AVI BIOPHARMA INC (SRPT) Snapshot price: $126.38

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 31
Form 3
—
0
—
—
0
No matching records found

MYMETICS CORP (MYMX) Snapshot price: $0.0016

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found